Sign Out
pms-IRBESARTAN (irbesartan) is indicated for the treatment of: Essential hypertension. pms-IRBESARTAN may be used alone or concomitantly with thiazide diuretics.
Hypertensive patients with type 2 diabetes mellitus and renal disease to reduce the rate of progression of nephropathy as measured by the reduction of microalbuminuria, and the occurrence of doubling of serum creatinine (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions).
Pediatrics: Pediatrics (< 18 years of age): The safety and efficacy of pms-IRBESARTAN in patients < 18 years of age have not been established. Therefore, Health Canada has not authorized an indication for pediatric use (see Use in Children under Precautions).
Geriatrics: Geriatrics (> 65 years of age): In clinical studies, no overall differences in safety or efficacy were observed between patients > 65 years of age and younger patients (see Use in the Elderly under Precautions).
